Market capitalization | €4.82b |
Enterprise Value | €4.86b |
P/E (TTM) P/E ratio | 53.45 |
EV/FCF (TTM) EV/FCF | 53.62 |
EV/Sales (TTM) EV/Sales | 485,613.00 |
P/S ratio (TTM) P/S ratio | 481,626.00 |
P/B ratio (TTM) P/B ratio | 2.62 |
Dividend yield | 0.96% |
Last dividend (FY25) | €1.04 |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
2 Analysts have issued a Financière De Tubize forecast:
2 Analysts have issued a Financière De Tubize forecast:
Dec '24 |
+/-
%
|
||
Revenue | 0.01 0.01 |
-
|
|
Gross Profit | -1.35 -1.35 |
-
|
|
EBITDA | -2.24 -2.24 |
19%
19%
|
EBIT (Operating Income) EBIT | -2.24 -2.24 |
18%
18%
|
Net Profit | 90 90 |
2%
2%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Financiere de Tubize SA is a holding company, which engages in investing in biopharmaceuticals industry. The company was founded on June 30, 1928 and is headquartered in Brussels, Belgium.
Head office | Belgium |
CEO | Anne-Sophe Pijcke |
Founded | 1928 |
Website | www.financiere-tubize.be |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.